LifeVantage Corporation announced the strategic acquisition of LoveBiome, a direct sales company focused on microbiome care and wellness solutions. The definitive agreement will allow LifeVantage to incorporate LoveBiome’s leadership in the emerging microbiome health sector into its current wellness mission to activate optimal health processes at the cellular level.
LoveBiome’s P84 product was designed to regulate, repair and restore the gut and microbiome through what it calls Activation, which LifeVantage believes will align well with its flagship Protandim family of products and the MindBody GLP-1 System.
“This strategic acquisition represents an acceleration of our mission to offer people around the world a better path to wellness and a healthy vibrant life while also serving as a natural expansion of our Activation philosophy,” said Steve Fife, LifeVantage President and CEO. “Kelly Olsen and his team have championed the direct sales industry, while innovating in a growing wellness category. We are thrilled to partner with LoveBiome and grow our reach. By combining their innovative microbiome solutions with our proven activation technologies, we’re able to activate wellness, both financial and physical, to a broader base of consumers.”
The company stated that the acquisition would also allow for growth of its consultant network in key markets, like the US, Taiwan and Europe, and would expand its product portfolio within the robust gut health supplement market. LoveBiome Founder and CEO Kelly Olsen will remain on staff to ensure continuity of operations.
The acquisition is expected to finalize by mid-October.
The post LifeVantage Acquires LoveBiome first appeared on Direct Selling News.
